Two years survival of primary cardiac leiomyosarcoma managed by surgical and adjuvant therapy.
Clin Sarcoma Res
; 7: 5, 2017.
Article
em En
| MEDLINE
| ID: mdl-28286642
BACKGROUND: Cardiac tumors are a very rare entity. Leiomyosarcoma represents less than 1% of cases. CASE PRESENTATION: a 51-year-old woman diagnosed with primary left atrium leiomyosarcoma. She was treated by optimal surgery and adjuvant chemotherapy. She is still alive after a follow-up of 24 months without evidence of local or distant recurrence. CONCLUSIONS: Cardiac leiomyosarcoma is a rare tumor with a dismal prognosis. Surgery is the mainstay of treatment. Adjuvant treatment is still controversial.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Tipo de estudo:
Prognostic_studies
Idioma:
En
Revista:
Clin Sarcoma Res
Ano de publicação:
2017
Tipo de documento:
Article
País de afiliação:
Tunísia
País de publicação:
Reino Unido